Showing results (471-480 of 314,526) with videos related to
Sort By:
Pageof 31,453
Antimicrobial Agents and Chemotherapy|December 25, 2003
In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and StreptococciHelio S Sader, David M Johnson, Ronald N JonesDiagnostic Microbiology and Infectious Disease|February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams in Taiwan medical centers. The Taiwan Antimicrobial Resistance Study GroupD J Biedenbach, D M Johnson, R N JonesDiagnostic Microbiology and Infectious Disease|February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study GroupD J Biedenbach, D M Johnson, R N JonesSexually Transmitted Diseases|August 24, 1999
A phase-II study of trovafloxacin for the treatment of Chlamydia trachomatis infectionsD H Martin, R B Jones, R B JohnsonMutagenesis|July 11, 2000
Isolation of camptothecin-sensitive chinese hamster cell mutants: phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation groupM A Johnson, P E Bryant, N J JonesQuarterly Journal of Experimental Physiology (Cambridge, England)|January 1, 1988
Magnesium metabolism in the rumens of lactating dairy cows fed on spring grassC L Johnson, S H Helliwell, D A JonesHospital & Health Services Administration|October 1, 1992
Administrative complement and managerial efficiency in South Carolina hospitalsR W Broyles, J A Johnson, W J JonesDiagnostic Microbiology and Infectious Disease|March 26, 1999
Anti-streptococcal activity of SB-265805 (LB20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelinesD M Johnson, R N Jones, M E ErwinHealthcare Financial Management : Journal of the Healthcare Financial Management Association|June 6, 1996
Capitating physician group practicesR L Barber, W J Jones, J A JohnsonAntimicrobial Agents and Chemotherapy|March 1, 1996
In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinonesR N Jones, D M Johnson, M E ErwinPageof 31,453